Nanae Hangai-Hoger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nanae Hangai-Hoger has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Amy G. Tsai
From the Department of Bioengineering, University of California, San Diego, La Jolla, CA (NHH, AGT, MI); La Jolla Bioengineering Institute, La Jolla, CA (AGT, PC, MI); and Department of Biochemistry & Integrative Medical Biology, School of Medicine, Keio University, Tokyo, Japan (MS)
3 shared publicationsMarcos Intaglietta
From the Department of Bioengineering, University of California, San Diego, La Jolla, CA (NHH, AGT, MI); La Jolla Bioengineering Institute, La Jolla, CA (AGT, PC, MI); and Department of Biochemistry & Integrative Medical Biology, School of Medicine, Keio University, Tokyo, Japan (MS)
3 shared publications- Pedro Cabrales
University of California San Diego
3 shared publications Barbara Friesenecker
1 shared publicationJuan C. Briceño
1 shared publication- Makoto Suematsu
Keio University
1 shared publication
Latest Publications
- 2 April 2007
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (4) , 1123-1132
Microvascular and systemic effects following top load administration of saturated carbon monoxide-saline solution*
Objective: To determine how top loads with different doses of carbon monoxide (CO)-saturated saline solutions (CO-saline) affect microvascular and systemic hemodynamics and to delineate the corresponding biochemical mechanisms. Design: Prospective study. Setting: University research laboratory. Subjects: Male Golden Syrian hamsters. Interventions: Hamsters implemented with a dorsal window chamber were given different volumes (characterized as percent of blood volume, BV) by intravenous injection of CO-saturated saline. Measurements and Main Results: Hamsters were observed until 90 mins after infusion of CO-saline solution. In the 20% BV CO-saline infusion group, observation was extended until 180 mins. Systemic variables measured included mean arterial pressure, heart rate, systemic arterial blood gases, and cardiac output and index. Microvascular hemodynamic measurements included vessel diameter, red blood cell velocity, and functional capillary density. Cyclic guanosine monophosphate (cGMP) content in the chamber tissue was measured by enzyme immunoassay. 10% BV of CO-saline increased flow maximally in the microcirculation at 30 mins after infusion (207% in arterioles and 238% in venules, p < .05 vs. baseline). Functional capillary density was significantly increased in both 10% and 15% groups (p < .05 vs. baseline), and cardiac index increased 130% (p < .05 vs. baseline) at 10 mins after 10% CO-saline infusion. There were no changes of microhemodynamic variables and functional capillary density with 2.5%, 5%, and 20% CO-saline infusion during the observation period. Microvascular hemodynamic changes by 10% CO-saline infusion were inhibited completely by L-NAME pretreatment and partially by 1H-[1,2,4]oxadiazole[4,3-a]quinoxqalin-1-one pretreatment. cGMP content in skin fold tissues was related to changes of vessel diameter. Conclusions: Intravenous injection of CO-saturated saline caused vasodilation and improved microvascular hemodynamics in the hamster window chamber model in a dose-dependent manner. These changes were related to increased cardiac output and local cGMP content. These results support the possible use of CO-saturated solutions as a vasodilator in critical conditions.
- 2 April 2007
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (4) , 1123-1132
Microvascular and systemic effects following top load administration of saturated carbon monoxide-saline solution*
Objective: To determine how top loads with different doses of carbon monoxide (CO)-saturated saline solutions (CO-saline) affect microvascular and systemic hemodynamics and to delineate the corresponding biochemical mechanisms. Design: Prospective study. Setting: University research laboratory. Subjects: Male Golden Syrian hamsters. Interventions: Hamsters implemented with a dorsal window chamber were given different volumes (characterized as percent of blood volume, BV) by intravenous injection of CO-saturated saline. Measurements and Main Results: Hamsters were observed until 90 mins after infusion of CO-saline solution. In the 20% BV CO-saline infusion group, observation was extended until 180 mins. Systemic variables measured included mean arterial pressure, heart rate, systemic arterial blood gases, and cardiac output and index. Microvascular hemodynamic measurements included vessel diameter, red blood cell velocity, and functional capillary density. Cyclic guanosine monophosphate (cGMP) content in the chamber tissue was measured by enzyme immunoassay. 10% BV of CO-saline increased flow maximally in the microcirculation at 30 mins after infusion (207% in arterioles and 238% in venules, p < .05 vs. baseline). Functional capillary density was significantly increased in both 10% and 15% groups (p < .05 vs. baseline), and cardiac index increased 130% (p < .05 vs. baseline) at 10 mins after 10% CO-saline infusion. There were no changes of microhemodynamic variables and functional capillary density with 2.5%, 5%, and 20% CO-saline infusion during the observation period. Microvascular hemodynamic changes by 10% CO-saline infusion were inhibited completely by L-NAME pretreatment and partially by 1H-[1,2,4]oxadiazole[4,3-a]quinoxqalin-1-one pretreatment. cGMP content in skin fold tissues was related to changes of vessel diameter. Conclusions: Intravenous injection of CO-saturated saline caused vasodilation and improved microvascular hemodynamics in the hamster window chamber model in a dose-dependent manner. These changes were related to increased cardiac output and local cGMP content. These results support the possible use of CO-saturated solutions as a vasodilator in critical conditions.
- Open Access
- 1 April 2005
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (4) , H1515-H1520
Microvascular oxygen delivery and consumption following treatment with verapamil
The microvascular distribution of oxygen was studied in the arterioles and venules of the awake hamster window chamber preparation to determine the contribution of vascular smooth muscle relaxation to oxygen consumption of the microvascular wall during verapamil-induced vasodilatation. Verapamil HCl delivered in a 0.1 mg/kg bolus injection followed by a continuous infusion of 0.01 mg·kg−1·min−1caused significant arteriolar dilatation, increased microvascular flow and functional capillary density, and decreased arteriolar vessel wall transmural Po2difference. Verapamil caused tissue Po2to increase from 25.5 ± 4.1 mmHg under control condition to 32.0 ± 3.7 mmHg during verapamil treatment. Total oxygen released by the microcirculation to the tissue remained the same as at baseline. Maintenance of the same level of oxygen release to the tissue, increased tissue Po2, and decreased wall oxygen concentration gradient are compatible if vasodilatation significantly lowers vessel wall oxygen consumption, which in this model appears to constitute an important oxygen-consuming compartment. These findings show that treatment with verapamil, which increases oxygen supply through vasodilatation, may further improve tissue oxygenation by lowering oxygen consumption of the microcirculation.
- 1 April 2005
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (4) , H1515-H1520
Open AccessMicrovascular oxygen delivery and consumption following treatment with verapamil
The microvascular distribution of oxygen was studied in the arterioles and venules of the awake hamster window chamber preparation to determine the contribution of vascular smooth muscle relaxation to oxygen consumption of the microvascular wall during verapamil-induced vasodilatation. Verapamil HCl delivered in a 0.1 mg/kg bolus injection followed by a continuous infusion of 0.01 mg·kg−1·min−1caused significant arteriolar dilatation, increased microvascular flow and functional capillary density, and decreased arteriolar vessel wall transmural Po2difference. Verapamil caused tissue Po2to increase from 25.5 ± 4.1 mmHg under control condition to 32.0 ± 3.7 mmHg during verapamil treatment. Total oxygen released by the microcirculation to the tissue remained the same as at baseline. Maintenance of the same level of oxygen release to the tissue, increased tissue Po2, and decreased wall oxygen concentration gradient are compatible if vasodilatation significantly lowers vessel wall oxygen consumption, which in this model appears to constitute an important oxygen-consuming compartment. These findings show that treatment with verapamil, which increases oxygen supply through vasodilatation, may further improve tissue oxygenation by lowering oxygen consumption of the microcirculation.
- Open Access
- 1 March 2004
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 286 (3) , H878-H883
Microlymphatic and tissue oxygen tension in the rat mesentery
Oxygen phosphorescence quenching was used to measure tissue Po2 of lymphatic vessels of 43.6 ± 23.1 μm (mean ± SD) diameter in tissue locations of the rat mesentery classified according to anatomic location. Lymph and adipose tissue Po2 were 20.6 ± 9.1 and 34.1 ± 7.8 mmHg, respectively, with the difference being statistically significant. Rare microlymphatic vessels in connective tissue not surrounded by microvessels had a Po2 of 0.8 ± 0.2 mmHg, whereas the surrounding tissue Po2 was 3.0 ± 3.2 mmHg, with both values being significantly lower than those of adipose tissue. Lower of lymph fluid Po2 relative to the surrounding tissue was also evident in paired measurements of Po2 in the lymphatic vessels and perilymphatic adipose tissue, which was significantly lower than the Po2 in paired adipose tissue. The Po2 of the lymphatic fluid of the mesenteric microlymphatics is consistently lower than that of the surrounding adipose tissue by ∼11 mmHg; therefore, lymph fluid has the lowest Po2 of this tissue. The disparity between lymph and tissue Po2 is attributed to the microlymphatic vessel wall and lymphocyte oxygen consumption.
- 1 March 2004
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 286 (3) , H878-H883
Open AccessMicrolymphatic and tissue oxygen tension in the rat mesentery
Oxygen phosphorescence quenching was used to measure tissue Po2 of lymphatic vessels of 43.6 ± 23.1 μm (mean ± SD) diameter in tissue locations of the rat mesentery classified according to anatomic location. Lymph and adipose tissue Po2 were 20.6 ± 9.1 and 34.1 ± 7.8 mmHg, respectively, with the difference being statistically significant. Rare microlymphatic vessels in connective tissue not surrounded by microvessels had a Po2 of 0.8 ± 0.2 mmHg, whereas the surrounding tissue Po2 was 3.0 ± 3.2 mmHg, with both values being significantly lower than those of adipose tissue. Lower of lymph fluid Po2 relative to the surrounding tissue was also evident in paired measurements of Po2 in the lymphatic vessels and perilymphatic adipose tissue, which was significantly lower than the Po2 in paired adipose tissue. The Po2 of the lymphatic fluid of the mesenteric microlymphatics is consistently lower than that of the surrounding adipose tissue by ∼11 mmHg; therefore, lymph fluid has the lowest Po2 of this tissue. The disparity between lymph and tissue Po2 is attributed to the microlymphatic vessel wall and lymphocyte oxygen consumption.